These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8981472)

  • 61. Novel behavioural characteristics of female APPSwe/PS1ΔE9 double transgenic mice.
    Cheng D; Low JK; Logge W; Garner B; Karl T
    Behav Brain Res; 2014 Mar; 260():111-8. PubMed ID: 24315833
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain.
    Arendash GW; Lewis J; Leighty RE; McGowan E; Cracchiolo JR; Hutton M; Garcia MF
    Brain Res; 2004 Jun; 1012(1-2):29-41. PubMed ID: 15158158
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease.
    Rockenstein E; Mallory M; Mante M; Alford M; Windisch M; Moessler H; Masliah E
    J Neural Transm Suppl; 2002; (62):327-36. PubMed ID: 12456076
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
    Yang H; Yang H; Xie Z; Wang P; Bi J
    Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dietary supplementation of walnuts improves memory deficits and learning skills in transgenic mouse model of Alzheimer's disease.
    Muthaiyah B; Essa MM; Lee M; Chauhan V; Kaur K; Chauhan A
    J Alzheimers Dis; 2014; 42(4):1397-405. PubMed ID: 25024344
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cognitive phenotyping of amyloid precursor protein transgenic J20 mice.
    Karl T; Bhatia S; Cheng D; Kim WS; Garner B
    Behav Brain Res; 2012 Mar; 228(2):392-7. PubMed ID: 22197298
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improved spatial learning strategy and memory in aged Alzheimer AβPPswe/PS1dE9 mice on a multi-nutrient diet.
    Wiesmann M; Jansen D; Zerbi V; Broersen LM; Garthe A; Kiliaan AJ
    J Alzheimers Dis; 2013; 37(1):233-45. PubMed ID: 23803297
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of methylphenidate on the behavior of male 5xFAD mice.
    Schneider F; Baldauf K; Wetzel W; Reymann KG
    Pharmacol Biochem Behav; 2015 Jan; 128():68-77. PubMed ID: 25449360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation.
    Gallagher JJ; Minogue AM; Lynch MA
    Neurodegener Dis; 2013; 11(1):33-41. PubMed ID: 22627185
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Optogenetic gamma stimulation rescues memory impairments in an Alzheimer's disease mouse model.
    Etter G; van der Veldt S; Manseau F; Zarrinkoub I; Trillaud-Doppia E; Williams S
    Nat Commun; 2019 Nov; 10(1):5322. PubMed ID: 31757962
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease.
    Morris GP; Clark IA; Vissel B
    Acta Neuropathol Commun; 2014 Sep; 2():135. PubMed ID: 25231068
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?
    Teich AF; Arancio O
    Biochem J; 2012 Sep; 446(2):165-77. PubMed ID: 22891628
    [TBL] [Abstract][Full Text] [Related]  

  • 73. APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).
    Lalonde R; Fukuchi K; Strazielle C
    Neurosci Biobehav Rev; 2012 May; 36(5):1357-75. PubMed ID: 22373961
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.
    Yan SS; Chen D; Yan S; Guo L; Du H; Chen JX
    Front Biosci (Schol Ed); 2012 Jan; 4(1):240-50. PubMed ID: 22202057
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function.
    Delay C; Calon F; Mathews P; Hébert SS
    Mol Neurodegener; 2011 Oct; 6():70. PubMed ID: 21982160
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease.
    Havas D; Hutter-Paier B; Ubhi K; Rockenstein E; Crailsheim K; Masliah E; Windisch M
    J Alzheimers Dis; 2011; 25(2):231-43. PubMed ID: 21403389
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.
    Origlia N; Righi M; Capsoni S; Cattaneo A; Fang F; Stern DM; Chen JX; Schmidt AM; Arancio O; Yan SD; Domenici L
    J Neurosci; 2008 Mar; 28(13):3521-30. PubMed ID: 18367618
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.
    Van Dam D; Abramowski D; Staufenbiel M; De Deyn PP
    Psychopharmacology (Berl); 2005 Jun; 180(1):177-90. PubMed ID: 15654502
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening.
    Chang L; Bakhos L; Wang Z; Venton DL; Klein WL
    J Mol Neurosci; 2003; 20(3):305-13. PubMed ID: 14501013
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling.
    Vitolo OV; Sant'Angelo A; Costanzo V; Battaglia F; Arancio O; Shelanski M
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13217-21. PubMed ID: 12244210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.